News & Insights
Sort By
Insights 1 result
Insights
|November 9, 2017
The Most Important New Privacy Law in a Generation: The GDPR
If you have any questions regarding the matters covered in this client alert, you may contact the following GD attorneys:
Client News 8 Results
Client News
|March 19, 2021
Boston Pharma Strategic License Arrangement with GlaxoSmithKline
Gunderson Dettmer represented client Boston Pharma, a clinical stage biopharmaceutical company developing differentiated therapeutics, in its strategic license arrangement with GSK.
Client News
|December 15, 2020
Overland Pharma Joint Venture with Allogene Therapeutics
Gunderson Dettmer represented client Overland Pharma in its joint venture with Allogene Therapeutics forming new company, Allogene Overland Biopharm, a separate venture that will develop, manufacture and commercialize allogeneic CAR T (AlloCAR T™) therapies for patients with cancer in greater China, Taiwan, South Korea and Singapore.
Client News
|December 14, 2020
Overland Pharma Joint Venture with ADC Therapeutics
Gunderson Dettmer represented client Overland Pharma in its joint venture with ADC Therapeutics forming new company, Overland ADCT BioPharma (CY) Limited, that will develop and commercialize four of ADC Therapeutics’ antibody drug conjugate (ADC) product candidates for difficult-to-treat hematologic and solid tumors in greater China and Singapore.